Obviously that’s not the case as he would have to notify on his holdings if they change.
Have you looked into FFWD. Another Jim Mellon fund with a focus on new technologies and emerging sectors.
If people look at ANIC and success it’s having I think this is positive for FFWD. As another Jim Mellon fund. If people do well on ANIC they will look for similar opportunities.
Yes it does. So the higher the btc price the more profit plus as btc gains momentum in price the volume is significantly increasing.
They use their equipment to validate transactions, for this service they get part of the transaction fee
Exactly the NAV has increased again. That’s the key
To correct that they would have around 1.75% if they kept their full stake
They sold around 2.5m and still have 1m shares. So they sold 70%. The equity figure has gone down because of dilution not because of anything ffwd have done. They would only have around 1.25% if they kept the full stake.
Where are you getting the 90% from?
More disposals due. Let’s wait and see.
Vemo is valued higher now than it was in last results, so that’s an increase in 11.4p nav. With cannabis investments in pipeline plus other disposals. Just based off current shareprice and discount to Nav this is extremely undervalued.
If you look at the last results in actually values Vemo higher so an increase in the 11.4p nav
More disposals and investments due that’s the key. Plus it increases the NAV which was already 11.4p
“We are pleased to have generated additional cash from this disposal while retaining 1m seed 2 shares representing approx 0.47% of #Vemo. We intend to invest the proceeds, approx £339,500, in the medical cannabis sector. #FFWD #medicinalcannabis
It’s not a sale to keep them ticking over. It clearly states that disposals are going to be made for cannabis investments.
The partial sale of the Company's interest in Vemo is the Company's first exit from an investment in 2019. The Board believes further investments can be realized during the course of 2019 and intends to reinvest the proceeds in the medicinal cannabis sector, furthering FFWDs investment focus on life science, health and technology."
£419k between directors
Hargreaves and Lansdown
At least £3m